Shares of IM Cannabis have experienced a decline after the company announced a 1-for-30 share consolidation.

IM Cannabis announced its GAAP EPS of -$0.38 and revenue of $8.7 million for the latest quarter.

IM Cannabis has reported its full-year financial results, leading to a decline in its share price.

IM Cannabis has announced its intention to sell IMC Holdings and its European assets to Slil, a CEO-controlled entity, a move that will impact its market presence.

Germany's partial legalization of cannabis is facing increasing scrutiny, with security politicians expressing doubts and calling for a reassessment of the law.

IM Cannabis has released its financial results for the second quarter.

IM Cannabis has received a notice from Nasdaq regarding its failure to meet the minimum bid price requirement for continued listing.